Library Logo

Detection and quantification of antibodies to biopharmaceuticals : practical and applied considerations / (Record no. 205173)

000 -LEADER
fixed length control field 05202cam a2200745Ka 4500
001 - CONTROL NUMBER
control field ocn739120274
003 - CONTROL NUMBER IDENTIFIER
control field OCoLC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20171116135243.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m o d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr cn|||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 110706s2011 nju ob 000 0 eng
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER
Canceled/invalid LC control number 2011002984
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781118075685
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1118075684
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781118075661
Qualifying information (e-book)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1118075668
Qualifying information (e-book)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0470566663
Qualifying information (Cloth)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780470566664
Qualifying information (Cloth)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 9780470566664
Qualifying information (cloth)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 9781118075678
Qualifying information (ePub)
024 8# - OTHER STANDARD IDENTIFIER
Standard number or code 9786613203854
029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC)
OCLC library identifier AU@
System control number 000049163109
029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC)
OCLC library identifier AU@
System control number 000053280047
029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC)
OCLC library identifier DKDLA
System control number 820120-katalog:000571996
029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC)
OCLC library identifier DKDLA
System control number 830060-katalog:10484657
029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC)
OCLC library identifier DKDLA
System control number 860900-katalog:10484657
029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC)
OCLC library identifier NZ1
System control number 15915613
029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC)
OCLC library identifier DEBBG
System control number BV043393313
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)739120274
Canceled/invalid control number (OCoLC)747412453
-- (OCoLC)751680753
-- (OCoLC)758670738
-- (OCoLC)961555913
-- (OCoLC)962625736
-- (OCoLC)966204491
037 ## - SOURCE OF ACQUISITION
Stock number 10.1002/9781118075685
Source of stock number/acquisition Wiley InterScience
Note http://www3.interscience.wiley.com
040 ## - CATALOGING SOURCE
Original cataloging agency DG1
Language of cataloging eng
Description conventions pn
Transcribing agency DG1
Modifying agency E7B
-- OCLCQ
-- CDX
-- YDXCP
-- N$T
-- OCLCQ
-- OCLCF
-- OCLCA
-- OCLCQ
-- NLGGC
-- OCLCQ
-- EBLCP
-- OCLCQ
-- DEBBG
-- AZK
-- LOA
-- OCLCO
-- OCLCA
-- MERER
-- OCLCO
049 ## - LOCAL HOLDINGS (OCLC)
Holding library MAIN
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number QR186.7
Item number .D48 2011
060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number QW 575
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 044000
Source bisacsh
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 616.07/98
Edition number 23
245 00 - TITLE STATEMENT
Title Detection and quantification of antibodies to biopharmaceuticals : practical and applied considerations /
Statement of responsibility, etc. [edited] by Michael G. Tovey.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc. Hoboken, N.J. :
Name of publisher, distributor, etc. Wiley,
Date of publication, distribution, etc. ©2011.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (xxiii, 404 pages)
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
347 ## - DIGITAL FILE CHARACTERISTICS
File type data file
Source rda
380 ## - FORM OF WORK
Form of work Bibliography
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Principals of risk assessment and monitoring of antibody responses to biopharmaceuticals / Eugen Koren, Erik Foehr, and Charles A. O'Neill -- Immunogenicity of therapeutic proteins : a regulatory perspective / Susan Kirshner -- Guidance on immunogenicity assessment of biologically-derived therapeutic proteins : an European perspective / Meenu Wadhwa and Robin Thorpe -- Japanese regulatory perspective on immunogenicity / Takao Hayakawa and Akiko Ishii -- Enzyme immunoassays and radioimmune assays for quantification of anti-TNF biopharmaceuticals and anti-drug antibodies / Klaus Bendtzen and Morten Svenson -- Confirmatory immunogenicity assays / Eric Wakshull and Daniel Coleman -- The use of pharmacodynamics as a surrogate marker for the detection of anti-drug neutralizing antibodies / Florian Deisenhammer -- Cell-based assays for the detection of neutralizing antibodies to interferon beta (IFN-?) and tumor necrosis factor-alpha (TNF-?) inhibitors / Anthony Meager -- Detection of neutralizing antibodies (NABs) to Interferon-beta by real time RT-PCR / Francesca Gilli and Antonio Bertolotto -- Competitive ligand binding assays for the detection of neutralizing antibodies / Bonnie Wu, George R. Gunn III, and Gopi Shankar.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note The use of surface plasmon resonance for the detection and characterization of antibodies / Steven J. Swanson and Daniel Mytych -- Hypersensitivity reactions to biopharmaceuticals : detection and quantification of drug-specific IgE antibodies / Jørgen Dahlstrøm and Lennart Venemalm -- Standardization and validation of immunoassays and biophysical assays for the detection of anti-drug antibodies / Daniel Kramer -- Standardization and validation of cell-based assays for the detection of neutralizing anti-drug antibodies / Deborah Finco-Kent and Amy Grenham -- Standardization of neutralizing antibody unitge by bioassay design : constant antigen and constant antibody methodology / Sidney E. Grossberg, Yoshimi Kawade, and Leslie D. Grossberg -- Cut-points and performance characteristics for anti-drug antibody assays / Viswanath Devanarayan and Michael G. Tovey -- Dilutional linearity for neutralizing antibody assays / David Lansky and Carrie Wager -- Detection of neutralizing antibodies to biopharmaceuticals in the presence of high levels of circulating drug / Arno Kromminga and Michael G. Tovey.
588 0# - SOURCE OF DESCRIPTION NOTE
Source of description note Print version record.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Immunoglobulins
General subdivision Analysis.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Immunoassay.
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL
General subdivision Immunology.
Source of heading or term bisacsh
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Immunoassay.
Source of heading or term fast
Authority record control number (OCoLC)fst00967921
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Immunoglobulins
General subdivision Analysis.
Source of heading or term fast
Authority record control number (OCoLC)fst00967962
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Antibodies, Neutralizing
General subdivision analysis.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Antibodies, Neutralizing
General subdivision immunology.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Biological Factors
General subdivision immunology.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Immunoassay
General subdivision methods.
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
655 #7 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
Source of term local
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tovey, Michael G.
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element Wiley InterScience (Online service)
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Print version:
Title Detection and quantification of antibodies to biopharmaceuticals.
Place, publisher, and date of publication Hoboken, N.J. : Wiley, ©2011
Record control number (DLC) 2011002984
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier http://onlinelibrary.wiley.com/book/10.1002/9781118075685
Public note Wiley Online Library
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme
Koha item type Books

No items available.

Last Updated on September 15, 2019
© Dhaka University Library. All Rights Reserved|Staff Login